Delivery Order SPE2DB22D1202-SPE2DB25FUVL1
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of "ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML", a pharmaceutical product, with a ceiling value of $17,596.92 and a completion date of June 27, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $8,191.64, is a delivery order contract for the provision of ZEPBOUND 10 MG/0.5 ML PEN 0.5ML medical products. The contract has a firm fixed price pricing type and a completion date of March 10, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,713.52 Firm Fixed Price Delivery Order contract is for the supply of "ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML" pharmaceutical products. The contract has an ultimate completion date of April 22, 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a substantial Indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $1,143.87 and is for the delivery of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML medical products. The contract is a firm fixed-price delivery order and has an ultimate completion date of April 7, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,850.06, is for the delivery of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML medical products. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of January 14, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,779.00, is a delivery order for the supply of a specific pharmaceutical product, 4567422477 ! ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, with an ultimate completion date of March 3, 2025. The contract is a firm fixed-price arrangement. This award is part of a larger Indefinite Delivery Contract (IDC)...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $8,238.74 and has a firm fixed price pricing type. The award is for the pharmaceutical product "ZEPBOUND 5 MG/0.5 ML PEN 0.5ML" and has a completion date of February 7, 2025. This contract is not associated with a set-aside designation. Amerisourcebergen Drug Corp holds a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,133.64, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, worth up to $999,999,999 through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,287.80, is a delivery order for the pharmaceutical product "ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML". The contract is a firm fixed-price arrangement with an ultimate completion date of April 8, 2025. This award is not associated with any set-aside designation. Amerisourcebergen Drug Corp, the...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $11,104.76 and a performance period ending on May 1, 2025. The contract is for the supply of the pharmaceutical product "ZEPBOUND 5 MG/0.5 ML PEN 0.5ML" and is not set aside for any special type of business. Amerisourcebergen Drug Corp holds a significant...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FUVL1Delivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,144.74, is for the delivery of a pharmaceutical product, ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML. This is a Firm Fixed Price Delivery Order contract with a period of performance through March 19, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor, and the contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.1k | 3/18/25 |